ATS 2017 International Conference - Mobile

123 RESPIRE 2: Ciprofloxacin DPI 32.5 mg b.i.d. Administered 14 Days On/Off or 28 Days On/Off Vs. Placebo for 48 Weeks in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFB)

Monday

May

22

2:15 PM

4:15 PM

Type : Late Breaking Abstract

Speaker(s)

Timothy R. Aksamit

Tiemo-Joerg Bandel

Margarita Criollo

J Stuart Elborn

Maxine Lau

Elisabeth Operschall

Eva Polverino

Elaine Montegriffo

Anthony De Soyza

Kevin L. Winthrop

Robert Wilson

Content

Parent Sessions

B103 CLINICAL STUDIES IN BRONCHIECTASIS, IMMUNODEFICIENCY, AND DRUG INDUCED LUNG DISEASE...
05-22-2017 2:15 PM - 4:15 PM